Nuclera (private company)

See something wrong or missing? Let us know
Offices:Cambridge
Business model:B2B

Nuclera is a a British protein manufacturing platform that makes biology accessible through desktop enzymatic protein and gene synthesis.

Investors: we tracked 14 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 143M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Nuclera

Name Criteria
France Core Biogenesis
67%
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 4
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Finland Enifer
67%
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 4
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
United Kingdom FabricNano
67%
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • At least one angel investor: found 2
  • At least one vc investor: found 6
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Denmark Reshape Biotech
67%
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • At least one angel investor: found 2
  • At least one vc investor: found 4
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Switzerland Mootral
67%
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • At least one angel investor: found 2
  • At least one vc investor: found 6
  • At least one other investor: found 4
  • Total raised in a similar range: 10M+ USD
Germany Insempra
67%
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • At least one angel investor: found 2
  • At least one vc investor: found 6
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Germany Formo
67%
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 6
  • At least one other investor: found 6
  • Total raised in a similar range: 10M+ USD
France Neoplants
67%
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 3
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom Mytos
67%
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • At least one angel investor: found 2
  • At least one vc investor: found 5
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Austria Arkeon Biotechnologies
67%
  • Similar verticals: Biotech, Manufacturing
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 5
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Top